Scrip
Catalyst halts patient enrolment to save cash
04 March 2009
Christopher Spillane
Please Login to read the full article.
04 March 2009
Christopher Spillane
Catalyst Pharmaceutical Partners will halt enrolment of new patients in its Phase II trial of CPP-109 (vigabatrin) for methamphetamine addiction to help reduce costs. The study will instead be converted into a smaller proof-of-concept trial.
The decision to treat only the 55 patients currently...
Please Login to read the full article.
RELATED CONTENT
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
